Structure-function relationships in Ca2+ cycling proteins

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 8, 2002, Pages 897-918

  MacLennan, David H ^a   Abu Abed, Mona ^a   Kang, ChulHee ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL L TYPE; CALMODULIN; CALSEQUESTRIN; CARRIER PROTEIN; PHOSPHOLAMBAN; POTASSIUM CHANNEL; SARCOLIPIN; SODIUM CALCIUM EXCHANGE PROTEIN; TROPONIN C; UNCLASSIFIED DRUG;

CALCIUM METABOLISM; CHANNEL GATING; HUMAN; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM; SODIUM CALCIUM EXCHANGE; STRUCTURE ACTIVITY RELATION;

EID: 0036702524     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2031     Document Type: Review

References (144)

1. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Kluwer Academic Press. 2001.
2. De Waard M, Gurnett CA, Campbell KP. Structural and functional diversity of voltage-activated calcium channels. Ion Channels 1996; 4: 41-87.
3. 2+ channels by G-protein beta gamma subunits. Nature 1996; 380: 258-262.
4. Yokoyama CT, Sheng ZH, Catterall WA. Phosphorylation of the synaptic protein interaction site on N-type calcium channels inhibits interactions with SNARE proteins. J Neurosci 1997; 17: 6929-6938.
5. + conduction and selectivity. Science 1998; 280: 69-77.
6. + channel-Fab complex at 2.0. A resolution. Nature 2001; 414: 43-48.
7. Zhou M, Morais-Cabral JH, Mann S, MacKinnon R. Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature 2001; 411: 657-661.
8. + selectivity filter. Nature 2001; 414: 37-42.
9. + channel and demonstration of its presence in the human BK channel. Neuron 2001; 29: 593-601.
10. Miller C. See potassium run. Nature 2001; 414: 23-24.
11. +-channel activation gating. Science 1999; 285: 73-78.
12. 2+ channel modulation by agonists and antagonists. Arch Biochem Biophys 2001; 393: 22-41.
13. Schneider MF, Chandler WK. Voltage dependent charge movement of skeletal muscle: A possible step in excitation-contraction coupling. Nature 1973; 242: 244-246.
14. Nakai J, Adams BA, Imoto K, Beam KG. Critical roles of the S3 segment and S3-S4 linker of repeat I in activation of L-type calcium channels. Proc Natl Acad Sci USA 1994; 91: 1014-1018.
15. Zhang JF, Ellinor PT, Aldrich RW, Tsien RW. Molecular determinants of voltage-dependent inactivation in calcium channels. Nature 1994; 372: 97-100.
16. 2+ channels. Science 1995; 270: 1502-1506.
17. 2+ channels due to phosphorylation by cAMP-dependent protein kinase. Nature 1993; 364: 240-243.
18. 2+ channel activity by deletions at the carboxyl terminus of the cardiac alpha 1 subunit. J Biol Chem 1994; 269: 1635-1640.
19. Tanabe T, Mikami A, Numa S, Beam KG. Cardiac-type excitation-contraction coupling in dysgenic skeletal muscle injected with cardiac dihydropyridine receptor cDNA. Nature 1990; 344: 451-453.
20. Tanabe T, Beam KG, Adams BA, Niidome T, Numa S. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature 1990; 346: 567-569.
21. Sheng ZH, Rettig J, Takahashi M, Catterall WA. Identification of a syntaxin-binding site on N-type calcium channels. Neuron 1994; 13: 1303-1313.
22. Monnier N, Procaccio V, Stieglitz P, Lunardi J. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 1997; 60: 1316-1325.
23. 2+ channel regulation by a conserved beta subunit domain. Neuron 1994; 13: 495-503.
24. Sather WA, Yang J, Tsien RW. Structural basis of ion channel permeation and selectivity. Curr Opin Neurobiol 1994; 4: 313-323.
25. 2+ channels. J Biol Chem 1997; 272: 30002-30008.
26. + channels. Science 2000; 289: 123-127.
27. Samso M, Wagenknecht T. Contributions of electron microscopy and single-particle techniques to the determination of the ryanodine receptor three-dimensional structure. J Struct Biol 1998; 121: 172-180.
28. Takeshima H, Nishimura S, Matsumoto T, Ishida H, Kangawa K, Minamino N, Matsuo H, Ueda M, Hanaoka M, Hirose T et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 1989; 339: 439-445.
29. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem 1990; 265: 2244-2256.
30. Serysheva, II, Orlova EV, Chiu W, Sherman MB, Hamilton SL, van Heel M. Electron cryomicroscopy and angular reconstitution used to visualize the skeletal muscle calcium release channel. Nat Struct Biol 1995; 2: 18-24.
31. Wagenknecht T, Radermacher M. Three-dimensional architecture of the skeletal muscle ryanodine receptor. FEBS Lett 1995; 369: 43-46.
32. Radermacher M, Rao V, Grassucci R, Frank J, Timerman AP, Fleischer S, Wagenknecht T. Cryo-electron microscopy and three-dimensional reconstruction of the calcium release channel/ryanodine receptor from skeletal muscle. J Cell Biol 1994; 127: 411-423.
33. Wagenknecht T, Radermacher M, Grassucci R, Berkowitz J, Xin HB, Fleischer S. Locations of calmodulin and FK506-binding protein on the three-dimensional architecture of the skeletal muscle ryanodine receptor. J Biol Chem 1997; 272: 32463-32471.
34. 2+ release channel. Biochemistry 1999; 38: 8532-8537.
35. Gaburjakova M, Jaburjako J, Reiken S, Huang F, Marx SO, Rosenblitt N, Marks AR. FKBP12 binding modulates ryanodine receptor channel. J Biol Chem 2001; 276: 16931-16935.
36. Benacquista BL, Sharma MR, Samso M, Zorzato F, Treves S, Wagenknecht T. Amino acid residues 4425-4621 localized on the three-dimensional structure of the skeletal muscle ryanodine receptor. Biophys J 2000; 78: 1349-1358.
37. Liu Z, Zhang J, Sharma MR, Li P, Chen SR, Wagenknecht T. Three-dimensional reconstruction of the recombinant type 3 ryanodine receptor and localization of its amino terminus. Proc Natl Acad Sci USA 2001; 98: 6104-6109.
38. 2+ and AMP-PCP. Biophys J 1999; 77: 1936-1944.
39. Orlova EV, Serysheva, II, van Heel M, Hamilton SL, Chiu W. Two structural configurations of the skeletal muscle calcium release channel. Nat Struct Biol 1996; 3: 547-552.
40. Zhao M, Li P, Li X, Zhang L, Winkfein RJ, Chen SR. Molecular identification of the ryanodine receptor pore-forming segment. J Biol Chem 1999; 274: 25971-25974.
41. 2+ release channel (ryanodine receptor) activity and conductance. Biophys J 2000; 79: 828-840.
42. 2+ release channel (ryanodine receptor isoform 2). J Biol Chem 2001; 276: 31760-31771.
43. Brandt NR, Caswell AH, Brandt T, Brew K, Mellgren RL. Mapping of the calpain proteolysis products of the junctional foot protein of the skeletal muscle triad junction. J Membr Biol 1992; 127: 35-47.
44. 2+-ATPases. J Biol Chem 1997; 272: 28815-28818.
45. 2+-ATPase vesicles treated with vanadate. J Biol Chem 1983; 258: 2599-2603.
46. 2+-ATPase in detergent-solubilized sarcoplasmic reticulum. J Biol Chem 1987; 262: 6439-6442.
47. 2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence. Nature 1985; 316: 696-700.
48. Zhang P, Toyoshima C, Yonekura K, Green NM, Stokes DL. Structure of the calcium pump from sarcoplasmic reticulum at 8-A resolution. Nature 1998; 392: 835-839.
49. 2--ATPase defines a new domain structure. Biophys J 2000; 78: 1765-1776.
50. 2+-ATPase and the ryanodine receptor. Eur J Biochem 2000; 267: 5274-5279.
51. 2+-ATPase. Nature 1989; 339: 476-478.
52. 2+-ATPase by site-directed mutagenesis. Biosci Rep 1995; 15: 243-261.
53. 2+ ATPase of sarcoplasmic reticulum. Acta Physiol Scand Suppl 1992; 607: 141-150.
54. Toyoshima C, Nakasako M, Nomura H, Ogawa H. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature 2000; 405: 647-655.
55. 2+-ATPase. Biochemistry 1999; 38: 5813-5821.
56. 2+-ATPase expressed in COS-1 cells. Proc Natl Acad Sci USA 1988; 85: 3314-3318.
57. 2+-ATPase: Probing nucleotide binding by multidimensional NMR. Biochemistry 2002; 41: 1156-1164.
58. 2+ pump of sarcoplasmic reticulum: A view along the lipid bilayer at 9-A resolution. Biophys J 1998; 75: 41-52.
59. +- and other cation transport ATPases. J Biol Chem 1988; 263: 8646-8657.
60. 2+ pump. J Biol Chem 1988; 263: 14152-14159.
61. 2+-H + exchange in reconstituted liposomal systems. J Biol Chem 1982; 257: 2350-2356.
62. 2+-ATPase. J Biol Chem 1981; 256: 8588-8592.
63. Strehler EE, Zacharias DA. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev 2001; 81: 21-50.
64. 2+ pump of human erythrocytes. J Biol Chem 1988; 263: 2905-2910.
65. 2+ pump contains a site that interacts with its calmodulin-binding domain. J Biol Chem 1991; 266: 2930-2936.
66. 2+ pump interacts with the transduction domain of the enzyme. Protein Sci 1992; 1: 1613-1621.
67. 2+-ATPase. J Biol Chem 1995; 270: 27812-27816.
68. 2+ pump. Biochemistry 1996; 35: 3290-3296.
69. Simmerman HK, Jones LR. Phospholamban: Protein structure, mechanism of action, and role in cardiac function. Physiol Rev 1998; 78: 921-947.
70. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 1994; 75: 401-409.
71. Haghighi K, Schmidt AG, Hoit BD, Brittsan AG, Yatani A, Lester JW, Zhai J, Kimura Y, Dorn GW 2nd, MacLennan DH, Kranias EG. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J Biol Chem 2001; 276: 24145-24152.
72. Adams PD, Arkin IT, Engelman DM, Brunger AT. Computational searching and mutagenesis suggest a structure for the pentameric transmembrane domain of phospholamban. Nat Struct Biol 1995; 2: 154-162.
73. Arkin IT, Rothman M, Ludlam CF, Aimoto S, Engelman DM, Rothschild KJ, Smith SO. Structural model of the phospholamban ion channel complex in phospholipid membranes. J Mol Biol 1995; 248: 824-834.
74. Simmerman HK, Kobayashi YM, Autry JM, Jones LR. A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J Biol Chem 1996; 271: 5941-5946.
75. Kimura Y, Kurzydlowski K, Tada M, MacLennan DH. Phospholamban inhibitory function is activated by depolymerization. J Biol Chem 1997; 272: 15061-15064.
76. Cornea RL, Jones LR, Autry JM, Thomas DD. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry 1997; 36: 2960-2967.
77. Reddy LG, Jones LR, Thomas DD. Depolymerization of phospholamban in the presence of calcium pump: A fluorescence energy transfer study. Biochemistry 1999; 38: 3954-3962.
78. 2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J Biol Chem 1997; 272: 15872-15880.
79. Frank S, Kammerer RA, Hellstern S, Pegoraro S, Stetefeld J, Lustig A, Moroder L, Engel J. Toward a high-resolution structure of phospholamban: Design of soluble transmembrane domain mutants. Biochemistry 2000; 39: 6825-6831.
80. Pollesello P, Annila A, Ovaska M. Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer. Biophys J 1999; 76: 1784-1795.
81. Lamberth S, Schmid H, Muenchbach M, Vorherr T, Krebs J, Carafoli E, Griesinger C. NMR structure of phospholamban. Helvetica Chimica Acta 2000; 83: 2141-2152.
82. Knighton DR, Zheng JH, Ten Eyck LF, Xuong NH, Taylor SS, Sowadski JM. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 1991; 253: 414-420.
83. 2+-ATPase of sarcoplasmic reticulum. J Biol Chem 1994; 269: 3088-3094.
84. 2+ pump of sarcoplasmic reticulum. Nature 1989; 342: 90-92.
85. 2+-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban. J Biol Chem 1994; 269: 22929-22932.
86. 2+-ATPase forms a functional interaction site with phospholamban. Evidence for physical interactions at other sites. J Biol Chem 1999; 274: 32855-32862.
87. 2+ ATPases. Proc Natl Acad Sci USA 2001; 98: 10061-10066.
88. Young HS, Jones LR, Stokes DL. Locating phospholamban in co-crystals with Ca(2 +)-ATPase by cryoelectron microscopy. Biophys J 2001; 81: 884-894.
89. MacLennan DH, Yip CC, Iles GH, Seeman P. Isolation of sarcoplasmic reticulum proteins. In: (eds). The Mechanism of Muscle Contraction. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. 1972: 469-478.
90. Wawrzynow A, Theibert JL, Murphy C, Jona I, Martonosi A, Collins JH. Sarcolipin, the "proteolipid" of skeletal muscle sarcoplasmic reticulum, is a unique, amphipathic, 31-residue peptide. Arch Biochem Biophys 1992; 298: 620-623.
91. Odermatt A, Taschner PE, Scherer SW, Beatty B, Khanna VK, Cornblath DR, Chaudhry V, Yee WC, Schrank B, Karpati G, Breuning MH, Knoers N, MacLennan DH. Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: Absence of structural mutations in five patients with Brody disease. Genomics 1997; 45: 541-553.
92. 2+-ATPase. Journal of Biological Chemistry 1998; 273: 12360-12369.
93. Gayan-Ramirez G, Vanzeir L, Wuytack F, Decramer M. Corticosteroids decrease mRNA levels of SERCA pumps, whereas they increase sarcolipin mRNA in the rat diaphragm. J Physiol 2000; 524(Pt 2): 387-397.
94. 2+-ATPases (SERCAs). J Biol Chem 2002; 41: 277.
95. Mascioni A, Karim C, Barany G, Thomas DD, Veglia G. Structure and orientation of sarcolipin in lipid environments. Biochemistry 2002; 41: 475-482.
96. Hellstern S, Pegoraro S, Karim CB, Lustig A, Thomas DD, Moroder L, Engel J. Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes. J Biol Chem 2001; 276: 30845-30852.
97. 2+ exchanger. J Biol Chem 2001; 276: 194-199.
98. 2+ exchanger. FEBS Lett 1999; 446: 264-268.
99. 2+ exchanger. J Biol Chem 1999; 274: 910-917.
100. Philipson KD, Nicoll DA. Sodium-calcium exchange: A molecular perspective. Annu Rev Physiol 2000; 62: 111-133.
101. 2+ exchanger. J Biol Chem 1991; 266: 1014-1020.
102. Shannon TR, Hale CC, Milanick MA. Interaction of cardiac Na-Ca exchanger and exchange inhibitory peptide with membrane phospholipids. Am J Physiol 1994; 266: C1350-C1356.
103. 2+. Mutational analysis of the Ca(2 +)-binding domain. J Gen Physiol 1995; 105: 403-420.
104. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 1996; 58: 447-481.
105. Li Y, Love ML, Putkey JA, Cohen C. Bepridil opens the regulatory N-terminal lobe of cardiac troponin C. Proc Natl Acad Sci USA 2000; 97: 5140-5145.
106. Phillips GN Jr, Fillers JP, Cohen C. Tropomyosin crystal structure and muscle regulation. J Mol Biol 1986; 192: 111-131.
107. Squire JM, Morris EP. A new look at thin filament regulation in vertebrate skeletal muscle. Faseb J 1998; 12: 761-771.
108. Sundaralingam M, Bergstrom R, Strasburg G, Rao ST, Roychowdhury P, Greaser M, WANG BC. Molecular structure of troponin C from chicken skeletal muscle at 3-angstrom resolution. Science 1985; 227: 945-948.
109. Herzberg O, James MN. Structure of the calcium regulatory muscle protein troponin-C at 2.8 Å resolution. Nature 1985; 313: 653-659.
110. Herzberg O, James MN. Refined crystal structure of troponin C from turkey skeletal muscle at 2.0 Å resolution. J Mol Biol 1988; 203: 761-779.
111. Satyshur KA, Rao ST, Pyzalska D, Drendel W, Greaser M, Sundaralingam M. Refined structure of chicken skeletal muscle troponin C in the two-calcium state at 2-A resolution. J Biol Chem 1988; 263: 1628-1647.
112. Sia SK, Li MX, Spyracopoulos L, Gagne SM, Liu W, Putkey JA, Sykes BD. Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain. J Biol Chem 1997; 272: 18216-18221.
113. Findlay WA, Sonnichsen FD, Sykes BD. Solution structure of the TR1C fragment of skeletal muscle troponin-C. J Biol Chem 1994; 269: 6773-6778.
114. 2+ sites on troponin C in the regulation of muscle contraction. Preparation and properties of troponin C depleted myofibrils. J Biol Chem 1982; 257: 7678-7683.
115. Grabarek Z, Tao T, Gergely J. Molecular mechanism of troponin-C function. J Muscle Res Cell Motil 1992; 13: 383-393.
116. Slupsky CM, Sykes BD. NMR solution structure of calcium-saturated skeletal muscle troponin C, Biochemistry 1995; 34: 15953-15964.
117. 2+-switch in the calmodulin superfamily. Structure 1997; 5: 1695-1711.
118. Gagne SM, Li MX, Sykes BD. Mechanism of direct coupling between binding and induced structural change in regulatory calcium binding proteins. Biochemistry 1997; 36: 4386-4392.
119. Spyracopoulos L, Li MX, Sia SK, Gagne SM, Chandra M, Solaro RJ, Sykes BD. Calcium-induced structural transition in the regulatory domain of human cardiac troponin C. Biochemistry 1997; 36: 12138-12146.
120. Paakkonen K, Sorsa T, Drakenberg T, Pollesello P, Tilgmann C, Permi P, Heikkinen S, Kilpelainen I, Annila A. Conformations of the regulatory domain of cardiac troponin C examined by residual dipolar couplings. Eur J Biochem 2000; 267: 6665-6672.
121. Babu YS, Sack JS, Greenhough TJ, Bugg CE, Means AR, Cook WJ. Three-dimensional structure of calmodulin. Nature 1985; 315: 37-40.
122. Babu YS, Bugg CE, Cook WJ. Structure of calmodulin refined at 2.2 Å resolution. J Mol Biol 1988; 204: 191-204.
123. Chattopadhyaya R, Meador WE, Means AR, Quiocho FA. Calmodulin structure refined at 1.7 resolution. J Mol Biol 1992; 228: 1177-1192.
124. Finn BE, Drakenberg T, Forsen S. The structure of apo-calmodulin. A 1H NMR examination of the carboxy-terminal domain. FEBS Lett 1993; 336: 368-374.
125. Zhang M, Tanaka T, Ikura M. Calcium-induced conformational transition revealed by the solution structure of apo calmodulin. Nat Struct Biol 1995; 2: 758-767.
126. Ikura M, Clore GM, Gronenborn AM, Zhu G, Klee CB, Bax A. Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science 1992; 256: 632-638.
127. Meador WE, Means AR, Quiocho FA. Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. Science 1992; 257: 1251-1255.
128. MacLennan DH, Wong PT. Isolation of a calcium-sequestering protein from sarcoplasmic reticulum. Proc Natl Acad Sci USA 1971; 68: 1231-1235.
129. Guo W, Campbell KP. Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum. J Biol Chem 1995; 270: 9027-9030.
130. Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997; 272: 23389-23397.
131. Rall J. Role of parvalbumin in skeletal muscle relaxation. News in Physiological Sciences 1996; 11: 249-255.
132. Fliegel L, Ohnishi M, Carpenter MR, Khanna VK, Reithmeier RA, MacLennan DH. Amino acid sequence of rabbit fast-twitch skeletal muscle calsequestrin deduced from cDNA and peptide sequencing. Proc Natl Acad Sci USA 1987; 84: 1167-1171.
133. Scott BT, Simmerman HK, Collins JH, Nadal-Ginard B, Jones LR. Complete amino acid sequence of canine cardiac calsequestrin deduced by cDNA cloning. J Biol Chem 1988; 263: 8958-8964.
134. Holmgren A, Soderberg BO, Eklund H, Branden CI. Three-dimensional structure of Escherichia coli thioredoxin-S2 to 2.8 A resolution. Proc Natl Acad Sci USA 1975; 72: 2305-2309.
135. 2+-binding sites. J Biol Chem 1991; 266: 9453-9459.
136. 2+-binding protein from sarcoplasmic reticulum. Arch Biochem Biophys 1986; 251: 369-378.
137. Somlyo AV, Gonzalez-Serratos HG, Shuman H, McClellan G, Somlyo AP. Calcium release and ionic changes in the sarcoplasmic reticulum of tetanized muscle: An electron-probe study. J Cell Biol 1981; 90: 577-594.
138. Franzini-Armstrong C, Kenney LJ, Varriano-Marston E. The structure of calsequestrin in triads of vertebrate skeletal muscle: A deep-etch study. J Cell Biol 1987; 105: 49-56.
139. Saito A, Seiler S, Chu A, Fleischer S. Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J Cell Biol 1984; 99: 875-885.
140. Maurer A, Tanaka M, Ozawa T, Fleischer S. Purification and crystallization of the calcium binding protein of sarcoplasmic reticulum from skeletal muscle. Proc Natl Acad Sci USA 1985; 82: 4036-4040.
141. Wang S, Trumble WR, Liao H, Wesson CR, Dunker AK, Kang CH. Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat Struct Biol 1998; 5: 476-483.
142. Williams RJP. The multifarious couplings of energy transduction. Biochim Biophys Acta 1978; 505: 1-44.
143. Kraulis PJ. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. Journal of Applied Crystallography 1991; 24: 946-956.
144. Strynadka NC, Cherney M, Sielecki AR, Li MX, Smillie LB, James MN. Structural details of a calcium-induced molecular switch: X-ray crystallographic analysis of the calcium-saturated N-terminal domain of troponin C at 1.75 Å resolution. J Mol Biol 1997; 273: 238-255.